• AdvaMed Applauds Senate Passage of Trade Promotion Bill

    By: Press Release | May 23, 2015

    “AdvaMed applauds passage by the Senate of bipartisan legislation which will allow America’s medical technology companies to provide life-changing innovations to more patients worldwide while helping one of the drivers of the U.S. economy continue to grow.  We especially commend Senate Finance Committee Chairman Orrin Hatch (R-Utah) and Ranking Member Ron Wyden (D-Ore.) for their tireless leadership to advance this bill."

  • Endovascular Stroke Treatment is Superior – Let’s Get to Work!

    By: Guest Blog Post | May 18, 2015

    Stroke from blockage of major blood vessels, known as acute ischemic stroke, causes lasting brain damage and is devastating to patients. This type of stroke becomes a ready-made target for procedures that reopen the vessel and restore blood flow easily performed using “endovascular” (from within the blood stream) techniques. Cerebrovascular and endovascular neurosurgeons have long been at the forefront of these type of procedures.

  • AdvaMed Statement On Chairman’s Mark For 21st Century Cures

    By: Press Release | May 13, 2015

    “AdvaMed commends Chairman Fred Upton (R-Mich.) and Representatives Diana DeGette (D-Colo.), Frank Pallone (D-N.J.), Joe Pitts (R-Pa.), and Gene Green (D-Texas) for their leadership on exploring ways to accelerate the discovery, development and delivery of new treatments and cures in the U.S. "

Innovation Agenda

The medical technology industry is central to the development of medical technologies that will provide the life-saving and life-enhancing treatments of the future. But the innovation ecosystem that supports medical technology is severely stressed.